logo

A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder.

This page provides detailed information about this publication. Please click on any text which is underlined to find more information.


Authors
Myriam Harfterkamp, Gigi van de Loo-Neus, Ruud B. Minderaa, Rutger Jan van der Gaag, Rodrigo Escobar, Alexander Schacht, Sireesha Pamulapati, Jan K. Buitelaar, Pieter J. Hoekstra
Title
A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder.
Journal
Journal of the American Academy of Child and Adolescent Psychiatry
Year
2012
Volume
5
Issue
7
Page(s)
pp. 733-741.
Abstract Link
Read Abstract (New Window)
Publication Format
Journal Article
Efficacy Study/Review
Yes
Scientific Validity
Randomised Trial, Placebo, Peer-Reviewed, Double Blind, Controlled Trial, Comparative Study
Comments
Clinical Trial No. NCT00380692
Keywords
Adolescent / Secondary School Age, Atomoxetine, Attention Deficit Hyperactivity Disorder, Autism, Child/Children, Intervention, Medication, Primary / Elementary School Age, Selective Noradrenaline Re-Uptake Inhibitor

Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.


Related Pages


Publications | Publications Database | Search Publications